BIOMAT Database Logo BIOMAT Database Logo

[Inhibitory effect of ticlopidine on platelet aggregation in open heart surgery]. 1987

S Shiguma, and S Tachibana, and K Asada, and M Ohzeki, and S Sasaki, and A Takeuchi

UI MeSH Term Description Entries
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D002315 Cardiopulmonary Bypass Diversion of the flow of blood from the entrance of the right atrium directly to the aorta (or femoral artery) via an oxygenator thus bypassing both the heart and lungs. Heart-Lung Bypass,Bypass, Cardiopulmonary,Bypass, Heart-Lung,Bypasses, Cardiopulmonary,Bypasses, Heart-Lung,Cardiopulmonary Bypasses,Heart Lung Bypass,Heart-Lung Bypasses
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006350 Heart Valve Prosthesis A device that substitutes for a heart valve. It may be composed of biological material (BIOPROSTHESIS) and/or synthetic material. Prosthesis, Heart Valve,Cardiac Valve Prosthesis,Cardiac Valve Prostheses,Heart Valve Prostheses,Prostheses, Cardiac Valve,Prostheses, Heart Valve,Prosthesis, Cardiac Valve,Valve Prostheses, Cardiac,Valve Prostheses, Heart,Valve Prosthesis, Cardiac,Valve Prosthesis, Heart
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D001463 Barbiturates A class of chemicals derived from barbituric acid or thiobarbituric acid. Many of these are GABA MODULATORS used as HYPNOTICS AND SEDATIVES, as ANESTHETICS, or as ANTICONVULSANTS.
D013923 Thromboembolism Obstruction of a blood vessel (embolism) by a blood clot (THROMBUS) in the blood stream. Thromboembolisms
D013988 Ticlopidine An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES. 53-32C,Ticlid,Ticlodix,Ticlodone,Ticlopidine Hydrochloride,53 32C,5332C,Hydrochloride, Ticlopidine

Related Publications

S Shiguma, and S Tachibana, and K Asada, and M Ohzeki, and S Sasaki, and A Takeuchi
Inhibitory effect of clentiazem (TA-3090) on platelet aggregation--alone and in combination with aspirin or ticlopidine.
July 1994, Thrombosis research,
S Shiguma, and S Tachibana, and K Asada, and M Ohzeki, and S Sasaki, and A Takeuchi
Inhibitory effect of staphylokinase on platelet aggregation.
November 1993, Thrombosis and haemostasis,
S Shiguma, and S Tachibana, and K Asada, and M Ohzeki, and S Sasaki, and A Takeuchi
Effect of vitamin E and ticlopidine on platelet aggregation in Fabry's disease.
May 1987, Clinical genetics,
S Shiguma, and S Tachibana, and K Asada, and M Ohzeki, and S Sasaki, and A Takeuchi
Enhancement by ticlopidine of the inhibitory effect on in vitro platelet aggregation of the glycoprotein IIb/IIIa inhibitor tirofiban.
November 1997, Thrombosis and haemostasis,
S Shiguma, and S Tachibana, and K Asada, and M Ohzeki, and S Sasaki, and A Takeuchi
Inhibitory effect of hexapeptide (RGRHGD) on platelet aggregation.
February 2000, Thrombosis research,
S Shiguma, and S Tachibana, and K Asada, and M Ohzeki, and S Sasaki, and A Takeuchi
Inhibitory effect of allyl isothiocyanate on platelet aggregation.
July 2014, Journal of agricultural and food chemistry,
S Shiguma, and S Tachibana, and K Asada, and M Ohzeki, and S Sasaki, and A Takeuchi
Inhibitory effect of hexahydrocurcumin on human platelet aggregation.
July 2012, Natural product communications,
S Shiguma, and S Tachibana, and K Asada, and M Ohzeki, and S Sasaki, and A Takeuchi
Effect of ticlopidine on exercise-induced platelet aggregation and exercise tolerance time in patients with ischemic heart disease.
April 1999, Journal of cardiovascular pharmacology,
S Shiguma, and S Tachibana, and K Asada, and M Ohzeki, and S Sasaki, and A Takeuchi
Point-of-care assessment of platelet aggregation in paediatric open heart surgery.
October 2011, British journal of anaesthesia,
S Shiguma, and S Tachibana, and K Asada, and M Ohzeki, and S Sasaki, and A Takeuchi
Effect of ticlopidine on platelet aggregation, adherence to damaged vessels, thrombus formation and platelet survival.
January 1985, Thrombosis research,
Copied contents to your clipboard!